Antidepressant use in the NL and the UK (SSRIs, TCAs, and other antidepressants) (A), segmentation of SSRI use in the NL (B), and in the UK (C).

<p>Dotted lines represent a change in use trend and therefore a new, or the end of a segment. *The grey periods represent the periods of media coverage of regulatory warnings.</p

SSRI use in the NL through GPs (A) and specialists (B), segmentation of paroxetine use in the NL through GPs (C) and specialists (D).

<p>Dotted lines represent a change in use trend and therefore a new, or the end of a segment. *The grey period illustrates the periods of media coverage of regulatory warnings.</p

Demographics for the Netherlands and the United Kingdom (2000–2009).

<p>Demographics for the Netherlands and the United Kingdom (2000–2009).</p

SSRI use in the NL in pediatrics (A), adolescents (B), young adults (C), and adults (D).

<p>*The grey period illustrates the period of media coverage of regulatory warnings.</p

SSRI use in the NL (A) and in the UK (B), segmentation of paroxetine in the NL (C) and in the UK (D).

<p>Dotted lines represent a change in use trend and therefore a new, or the end of a segment. *The grey period illustrates the periods of media coverage of regulatory warnings.</p